Article

The Effectiveness of Bivalent mRNA Omicron Containing Booster Vaccines Among Patients with Hematological Neoplasms

2023-02-03

Abstract excerpt

Purpose: Last year was characterized by an escape phenomenon of the SARS-CoV-2 virus generating novel variants, mainly the omicron sub-lineages BA.2.12.1, BA.4 and BA.5, which have confirmed resistance to the acquired immune response developed following first-generation mRNA vaccines. Given the ability to use mRNA technology to respond quickly to variant strains, novel bivalent vaccines against novel omicron varia...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8a45517c-0b9f-5b27-a557-8c3292347e26
DOI: 10.2139/ssrn.4343759

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Effectiveness of Bivalent mRNA Omicron Containing Booster Vaccines Among Patients with Hematological NeoplasmsDOI 10.2139/ssrn.4343759Read

COVID-19 mRNA Booster Vaccines Elicit Strong Protection Against SARS-CoV-2 Omicron Variant in Patients with CancerSemantic proximity Read

A Bivalent Omicron-containing Booster Vaccine Against Covid-19Semantic proximity Read

Effectiveness of mRNA COVID-19 Booster Vaccines against Omicron and Delta Variants among US VeteransSemantic proximity Read

Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim resultsSemantic proximity Read

Bivalent mRNA vaccine improves antibody-mediated neutralization of many SARS-CoV-2 Omicron lineage variantsSemantic proximity Read

Early Real-World Evidence on the Relative SARS-CoV-2 Vaccine Effectiveness of Bivalent COVID-19 Booster Doses: a Narrative ReviewSemantic proximity Read

Safety and Immunogenicity of Omicron BA.4/BA.5 Bivalent Vaccine Against Covid-19Semantic proximity Read

Three-month Antibody Persistence of a Bivalent Omicron-containing Booster Vaccine Against COVID-19Semantic proximity Read

Early real world evidence on the relative SARS-COV-2 vaccine effectiveness of bivalent COVID-19 booster doses: a rapid reviewSemantic proximity Read

Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boostersSemantic proximity Read

Effectiveness of Homologous and Heterologous Covid-19 Boosters against OmicronSemantic proximity Read

Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscapeSemantic proximity Read